Publikationen

Myalgische Enzephalomyelitis / Chronisches Fatigue-Syndrom (ME/CFS)

Myalgische Enzephalomyelitis bzw. Chronisches Fatigue-Syndrom
https://pubmed.ncbi.nlm.nih.gov/35925074/

Ballering AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM; Lifelines Corona Research Initiative. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022 Aug 6;400(10350):452-461. doi: 10.1016/S0140-6736(22)01214-4. PMID: 35934007; PbMCID: PMC9352274.
Steinbeis F, Thibeault C, Doellinger F, Ring RM, Mittermaier M, Ruwwe-Glösenkamp C, Alius F, Knape P, Meyer HJ, Lippert LJ, Helbig ET, Grund D, Temmesfeld-Wollbrück B, Suttorp N, Sander LE, Kurth F, Penzkofer T, Witzenrath M, Zoller T. Severity of respiratory failure and computed chest tomography in acute COVID-19 correlates with pulmonary function and respiratory symptoms after infection with SARS-CoV-2: An observational longitudinal study over 12 months. Respir Med. 2022 Jan;191:106709

https://pubmed.ncbi.nlm.nih.gov/34871947/

C Kedor, H Freitag, L Meyer-Arndt, K Wittke, T Zoller, F Steinbeis, M Haffke, G Rudolf, B Heidecker, HD Volk, C Skurk, F Paul, J Bellmann-Strobl, C Scheibenbogen. Chronic COVID-19 Syndrome and Chronic Fatigue Syndrome (ME/CFS) following the first pandemic wave in Germany – a first analysis of a prospective observational study

https://www.medrxiv.org/content/10.1101/2021.02.06.21249256v1

Association of cerebrospinal fluid brain-binding autoantibodies with cognitive impairment in post-COVID-19 syndrome
https://pubmed.ncbi.nlm.nih.gov/36657623/
Fatigue and cognitive impairment after COVID-19: A prospective multicentre study
https://pubmed.ncbi.nlm.nih.gov/36133318/

Greenhalgh T, Knight M, A'Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020 Aug 11;370:m3026. doi: 10.1136/bmj.m3026. PMID: 32784198.

https://www.bmj.com/content/370/bmj.m3026

Long COVID: major findings, mechanisms and recommendations
https://pubmed.ncbi.nlm.nih.gov/36639608/
Castanares-Zapatero D, Chalon P, Kohn L, Dauvrin M, Detollenaere J, Maertens de Noordhout C, Primus-de Jong C, Cleemput I, Van den Heede K. Pathophysiology and mechanism of long COVID: a comprehensive review. Ann Med. 2022 Dec;54(1):1473-1487. doi: 10.1080/07853890.2022.2076901. PMID: 35594336; PMCID: PMC9132392
Jasimuddin A., Jeffrey L.. Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches. J Clin Invest. 2022;132(15):e161167.
https://doi.org/10.1172/JCI161167.
Monje M, Iwasaki A. The neurobiology of long COVID. Neuron. 2022 Nov 2;110(21):3484-3496. doi: 10.1016/j.neuron.2022.10.006. Epub 2022 Oct 7. PMID: 36288726; PMCID: PMC9537254.

Arman Fesharaki-Zadeh, Naomi Lowe, Amy F.T. Arnsten, Clinical experience with the α2A-adrenoceptor agonist, guanfacine, and N-acetylcysteine for the treatment of cognitive deficits in “Long-COVID19”, Neuroimmunology Reports, Volume 3, 2023, 100154,
https://doi.org/10.1016/j.nerep.2022.100154.
Dal Negro RW, Turco P, Povero M. Nebivolol: an effective option against long-lasting dyspnoea following COVID-19 pneumonia - a pivotal double-blind, cross-over controlled study. Multidiscip Respir Med. 2022 Dec 23;17:886. doi: 10.4081/mrm.2022.886. PMID: 36636645; PMCID: PMC9830396.
Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023 Jan 13:1–14. doi: 10.1038/s41579-022-00846-2. Epub ahead of print. PMID: 36639608; PMCID: PMC9839201.
DeMars, J., Brown, D.A., Angelidis, I. et al. What is Safe Long COVID Rehabilitation?. J Occup Rehabil (2022).
https://doi.org/10.1007/s10926-022-10075-2
Ledford H. Long-COVID treatments: why the world is still waiting. Nature. 2022 Aug;608(7922):258-260. https://doi.org/10.1038/d41586-022-02140-w